SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual GuidanceGlobeNewsWire • 05/01/23
SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare ConferenceGlobeNewsWire • 04/24/23
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 GuidanceGlobeNewsWire • 02/27/23
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022GlobeNewsWire • 01/09/23
SI-BONE to Host a Virtual Fireside Chat at the 25th Annual Needham Growth ConferenceGlobeNewsWire • 01/03/23
SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite® Implant SystemGlobeNewsWire • 12/27/22
SI-BONE, Inc. (SIBN) CEO Laura Francis on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 11/08/22
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2022 and Updates GuidanceGlobeNewsWire • 11/07/22
Si-Bone (SIBN) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/31/22
Does Si-Bone (SIBN) Have the Potential to Rally 42% as Wall Street Analysts Expect?Zacks Investment Research • 08/29/22
SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare ConferenceGlobeNewsWire • 08/23/22
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 50%: Here's is How to TradeZacks Investment Research • 08/11/22
SI-BONE, Inc. (SIBN) CEO Laura Francis on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22
Analysts Estimate Si-Bone (SIBN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 08/01/22
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant SystemGlobeNewsWire • 06/13/22